Ember Therapeutics is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.
1
Deals
1467
Views
Viewed
less than a minute ago
1
Saves
Ember Therapeutics is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.
1467
Views
1
Followers
1
Deals
Sponsor Details
People
People
Deals
Partners
Key Markets
Competitors
Agencies
Analytics
Log In or Sign Up Free to access sponsorship data and contacts from this brand.
Free
✓
Access exclusive brand database and sponsorship deal analytics
✓
Unlock key decision maker contacts from brands that want to reach your audience
✓
Book more meetings with potential sponsors than even before
If you currently work at this organization, click the “Do you work here?” button to request editing privileges.
This SponsorPitch page is about Ember Therapeutics and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with Ember Therapeutics, though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Do you work here button to request management privileges. All trademarks, service marks and copyrights are property of their respective owners.
Please log in to access this feature. Don't have an account? Sign up today!